Lionco Pharmaceutical Group Co.,Ltd. (SHA:603669)
China
· Delayed Price · Currency is CNY 4.610
-0.050 (-1.07%)
Mar 11, 2026, 3:00 PM CST
SHA:603669 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 10, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 3,279 | 3,694 | 3,988 | 4,140 | 7,204 | 6,150 | Upgrade
|
| Market Cap Growth | -14.65% | -7.39% | -3.66% | -42.54% | 17.15% | 64.41% | Upgrade
|
| Enterprise Value | 3,372 | 3,626 | 3,740 | 3,720 | 6,568 | 5,675 | Upgrade
|
| Last Close Price | 4.66 | 5.25 | 5.53 | 5.74 | 9.84 | 8.30 | Upgrade
|
| PE Ratio | - | - | - | - | 109.32 | 38.42 | Upgrade
|
| Forward PE | - | 16.63 | 16.63 | 16.63 | 16.63 | 16.63 | Upgrade
|
| PS Ratio | 7.61 | 9.73 | 20.26 | 14.31 | 9.73 | 6.14 | Upgrade
|
| PB Ratio | 4.46 | 4.80 | 4.28 | 3.65 | 4.94 | 4.16 | Upgrade
|
| P/TBV Ratio | 5.13 | 5.52 | 4.85 | 4.06 | 5.41 | 4.47 | Upgrade
|
| P/FCF Ratio | - | - | - | - | 97.77 | 94.81 | Upgrade
|
| P/OCF Ratio | - | - | - | - | 56.07 | 48.50 | Upgrade
|
| EV/Sales Ratio | 7.83 | 9.55 | 19.00 | 12.86 | 8.87 | 5.67 | Upgrade
|
| EV/EBITDA Ratio | - | - | - | - | 84.39 | 40.47 | Upgrade
|
| EV/EBIT Ratio | - | - | - | - | 170.96 | 55.28 | Upgrade
|
| EV/FCF Ratio | -20.33 | - | - | - | 89.14 | 87.50 | Upgrade
|
| Debt / Equity Ratio | 0.39 | 0.34 | 0.61 | 0.55 | 0.65 | 0.60 | Upgrade
|
| Debt / EBITDA Ratio | - | - | - | - | 11.64 | 6.33 | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | 12.88 | 13.68 | Upgrade
|
| Net Debt / Equity Ratio | 0.13 | -0.03 | -0.18 | -0.30 | -0.42 | -0.58 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.60 | 0.26 | 1.34 | 2.57 | -7.93 | -6.13 | Upgrade
|
| Net Debt / FCF Ratio | -0.56 | 0.18 | 2.76 | 3.16 | -8.37 | -13.25 | Upgrade
|
| Asset Turnover | 0.36 | 0.26 | 0.11 | 0.13 | 0.28 | 0.43 | Upgrade
|
| Inventory Turnover | 3.93 | 4.88 | 2.08 | 1.88 | 2.58 | 2.08 | Upgrade
|
| Quick Ratio | 2.65 | 2.43 | 3.30 | 3.51 | 2.62 | 2.64 | Upgrade
|
| Current Ratio | 3.11 | 2.68 | 3.63 | 3.74 | 2.76 | 2.79 | Upgrade
|
| Return on Equity (ROE) | -14.88% | -15.38% | -14.67% | -15.10% | 4.49% | 11.46% | Upgrade
|
| Return on Assets (ROA) | -3.94% | -4.74% | -6.11% | -5.06% | 0.92% | 2.77% | Upgrade
|
| Return on Invested Capital (ROIC) | -9.56% | -14.46% | -21.91% | -21.70% | 4.91% | 13.92% | Upgrade
|
| Return on Capital Employed (ROCE) | -7.50% | -10.50% | -12.30% | -11.40% | 2.10% | 5.20% | Upgrade
|
| Earnings Yield | -3.61% | -3.54% | -3.80% | -4.73% | 0.92% | 2.60% | Upgrade
|
| FCF Yield | -5.06% | -3.24% | -1.53% | -2.64% | 1.02% | 1.05% | Upgrade
|
| Dividend Yield | - | - | - | - | 1.02% | 2.41% | Upgrade
|
| Payout Ratio | - | - | - | - | 241.58% | 70.59% | Upgrade
|
| Buyback Yield / Dilution | -2.34% | - | -0.17% | -0.18% | 5.75% | -5.87% | Upgrade
|
| Total Shareholder Return | -2.34% | - | -0.17% | -0.18% | 6.76% | -3.46% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.